Article thumbnail
Location of Repository

Signals from adipose tissue in morbid obesity and effect on depot specific differences

By R. Madani


Signals from adipose tissue, such as interleukin-6 (IL-6) and asymmetric dimethyl arginine (ADMA), an endogenous nitric oxide inhibitor, explain the link between obesity and metabolic diseases. Previously published human studies have used omental adipose tissue to study visceral depots, based on the assumption that all visceral adipose tissues are similar. This study, for the first time, assessed the release of five adipokines (adiponectin, leptin, IL-6, MCP-1 and RANTES) from the subcutaneous and two omental depots. Components of the cyclooxygenase (COX) and the nitric oxide (NO) pathways, that regulate cytokine release in other tissues, were also investigated for their putative role(s) in mediating adipokine release. RANTES release was greatest from the gastric fat pad. However, significantly higher circulating RANTES levels suggest that adipose tissue is unlikely to be the main source of RANTES release. Inhibition of the COX pathway, especially COX-2, reduced IL-6 release from subcutaneous adipose tissue. Prostacyclin synthase (PGI2S) activity was higher in the omental tissue and its protein expression was elevated in the stromavascular fraction from this depot. PGI2S activity appears to mainly reside in the non-adipocyte cells and is more coupled to IL-6 production in adipose tissue. Serum insulin and CRP levels, and systolic blood pressure, directly associated with subcutaneous tissue ADMA content, while BMI correlated with omental ADMA release. ADMA release was higher from the omental depot. However, while DDAH2 expression was higher compared to DDAH1 in adipose tissue, there was no depot specific difference in the expression of either isoform. In conclusion, this study showed adipose depot specific differences of RANTES release, a novel adipokine, from a hitherto poorly studied depot, the gastric fat pad. Characteristics of the omental adipose tissues differed depending on location and paracrine factors that may mediate the adipokine release. These regulatory pathways included components of the COX and NO pathways

Publisher: UCL (University College London)
Year: 2009
OAI identifier:
Provided by: UCL Discovery

Suggested articles


  1. (1998). A cytokine network in human diploid fibroblasts: Interactions of /Mnterferons, tumor necrosis factor, plateletderived growth factor, and interleukin-1. Mol Cell Biol. 1987;7:273-280 Kopelman PG. Obesity as a medical problem.
  2. (2008). Abnormal SPECT myocardial perfusion imaging during periods of obstructive sleep apnea in morbid obese patients without known heart disease. Rev Invest Clin. 2003;55:18–25 O’Rahilly
  3. (2004). Adiponectin differentially regulate cytokines in porcine macrophages. Biochem Biophys Res Commun.
  4. (2004). Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology.
  5. (2008). Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate
  6. (2003). Adv Surg Tech A.
  7. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ res. 2004;94:253-261 Wadden TA and Foster GD. Behavioral treatment of obesity. Med Clin North Am.
  8. (2004). Asymmetric 115 dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res.
  9. (1988). Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects.
  10. (2003). Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a 120 potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis and Vascular Biology.
  11. (1998). Fredrickson DS.Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502 Friedman JM and Halaas JL. Leptin and the regulation of body weight in mammals.
  12. (1998). Further evidence for a central role of adipose tissue in the antihyperglycemic effect of Metformin. Diabetes Care.
  13. (1986). Gastrointestinal surgery for severe obesity: National Institutes of Health Concensus Development Conference Statement. Am
  14. (2008). Hypertension in mice lacking the gene for endothelial nitric oxide synthase.
  15. (1998). Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes.
  16. (2000). Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord.
  17. (2009). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med.
  18. (1996). Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis.
  19. (2004). Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol.
  20. (1992). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem and Biophys Res Commu. 1999;257;79–83 Arner P. Not all fat is alike.
  21. Plasma Asymmetric Dimethylarginine Concentrations are Elevated in Obese InsulinResistant Women and Fall with Weight Loss.
  22. (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev.
  23. (1997). Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet.
  24. (1988). Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta2- interferon/hepatocyte-stimulating factor/ interleukin-6 gene in virus-infected human fibroblasts. J Exp Med.
  25. (1987). Separation and comparison of two monokines with LAF activity (interleukin-l/? and hybridoma growth factor): identification of leukocyte- derived HGF as interleukin-6.
  26. (1987). The laparoscopic adjustable gastric and (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg.
  27. (1998). Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J of Clin Endo and Metab.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.